ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 2794

Apolipoprotein B Binds to Enolase-1 and Aggravates Inflammation in Rheumatoid Arthritis

Joo Youn Lee1, Min Jueng Kang1, Ji Yong Choi2, Ji Soo Park3, Jin Kyun Park1,2, Eun Young Lee4, Eun Bong Lee5, Thomas Pap6, Eugene Yi1 and Yeong Wook Song1,2, 1Department of Molecular medicine and biopharmaceutical science, Seoul National University, seoul, Korea, Republic of (South), 2Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, Korea, Republic of (South), 3Department of Molecular medicine and biopharmaceutical science, Seoul National University, Seoul, Korea, Republic of (South), 4Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South), 5Division of Rheumatology, Department of Internal Medicine, Seoul National University, seoul, Korea, Republic of (South), 6Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: cytokines, inflammation and rheumatoid arthritis (RA)

Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis I

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by synovial inflammation and joint destruction. Monocytes and synovial macrophages are key players in inflammatory process of RA. Enolase-1 (ENO1) is a multifunctional glycolytic enzyme in cytoplasm of cells and it is also found on the cell surface as plasminogen receptor. The majority of cells expressing ENO1 in peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) derived from RA patients were known to be CD14-positive monocytes and macrophages. This study was aimed to discover and investigate a novel ligand of cell surface expressed ENO1 and biological role of the interaction between ENO1 and its novel ligand, apolipoprotein B (apoB).

Methods: ENO1 binding protein was identified present in RA synovial fluid (SF) using affinity-base mass spectrometry analysis. The interaction between ENO1 and apoB was evaluated using physical characterization, such as ligand blotting assay, ligand binding assay, surface plasmon resonance (SPR), and confocal microscopy. The production of pro-inflammatory cytokines in PBMCs from RA or healthy control (HC) after stimulation with apoB were evaluated using cytokines ELISA. The pro-inflammatory effect of apoB was evaluated in K/BxN serum transfer arthritis mouse model.

Results: Characterization of physical interaction between ENO1 and apoB using various binding assay, ligand blotting assay, ligand binding assay, SPR, and confocal microscopy showed that apoB is a novel ligand of ENO1. Interaction between surface ENO1 and apoB induced higher levels of pro-inflammatory cytokines in RA PBMCs than HC PBMCs. When surface ENO1 expression was down-regulated after transfection with ENO1-specific siRNA, production of inflammatory cytokines by RA PBMCs in response to apoB stimulation decreased. Moreover, in K/BxN serum transfer arthritis model, mice were immunized with K/BxN serum and apoB induced exacerbation of arthritis with increased ankle thickness, arthritis score, and production of pro-inflammatory cytokines. LDLR knockout mice are known to have high levels of serum LDL and apoB. The arthritis score and ankle thickness were markedly higher in low density lipoproteins receptor (LDLR) knockout mice compared to wild type after K/BxN serum transfer.

Conclusion: In this study, we discovered apoB as a novel ligand of ENO1. ApoB may enhance chronic inflammation in RA patients.


Disclosure: J. Y. Lee, None; M. J. Kang, None; J. Y. Choi, None; J. S. Park, None; J. K. Park, None; E. Y. Lee, None; E. B. Lee, None; T. Pap, None; E. Yi, None; Y. W. Song, None.

To cite this abstract in AMA style:

Lee JY, Kang MJ, Choi JY, Park JS, Park JK, Lee EY, Lee EB, Pap T, Yi E, Song YW. Apolipoprotein B Binds to Enolase-1 and Aggravates Inflammation in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/apolipoprotein-b-binds-to-enolase-1-and-aggravates-inflammation-in-rheumatoid-arthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/apolipoprotein-b-binds-to-enolase-1-and-aggravates-inflammation-in-rheumatoid-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology